In patients with low but rising PSA serum values after definitive local therapy, it is important to identify the sites of recurrence early to maximize the effects of treatment; localizing the PCa recurrence can impact treatment decisions as local recurrence can be treated with focal radiation therapy, whereas distant metastases require more systemic therapies [1]. This evidence concerns the gene KLK3 and posterior cortical atrophy.